Диссертация (1139468), страница 39
Текст из файла (страница 39)
- 2008 – Vol 121(1)-P.38-42.347. Yang T. Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. / Yang T. [et al.] //Heart Rhythm. -2010- Vol7(9)- P.1246–1252.348. Yin Y. Prospective randomized study comparing amiodarone vs.amiodarone plus losartan vs. amiodarone plus perindopril for the prevention ofatrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation./Yin Y.
[et al.] // Eur Heart J – 2006 –Vol 27- P.1841– 6.260349. Youn JY. Oxidative stress in atrial fibrillation: an emerging role ofNADPH oxidase./ Youn JY. [et al.] //J Mol Cell Cardiol- 2013-Vol 62-P.72–9.350. Yusuf S. Effects of the angiotensin-receptor blocker telmisartan oncardiovascular events in high-risk patients intolerant to angiotensin-convertingenzyme inhibitors: a randomized controlled trial.
/ Yusuf S. [et al.] //Lancet2008-Vol 372-P.1174–83.351. Zhang SH. The role of spironolactone in the metabolism of serumtype I collagen in elderly patients with atrial fibrillation. / Zhang SH. [et al.]//Eur Rev Med Pharmacol Sci. - 2014 – Vol 18(19)-P. 2903-7.352. Zhang YY. Predictors of Progression of Recently Diagnosed AtrialFibrillation in Registry on Cardiac Rhythm DisORDers Assessing the Control ofAtrial Fibrillation (RecordAF)-United States Cohort. / Zhang YY.
[et al.] //Am JCardiol -2013- Vol 112-P. 79–84.353. Zhao ZH. Inositol-1,4,5-trisphosphate and ryanodine-dependentCa2+ signaling in a chronic dog model of atrial fibrillation./ Zhao ZH. [et al.]//Cardiology. – 2007- Vol 107(4)- P. 269–276.354.
Zheng Z. Perioperative rosuvastatin in cardiac surgery./ Zheng Z. [etal.] // N Engl J Med – 2016- Vol 374- P.1744–53.355. Zimmerman D. Systematic review and meta-analysis of incidence,prevalence and outcomes of atrial fibrillation in patients on dialysis. /Zimmerman D. [et al.] //Nephrol Dial Transplant -2012- Vol 27- P.3816-22..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
